Growth Metrics

Solid Biosciences (SLDB) Depreciation & Amortization (CF) (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Depreciation & Amortization (CF) for 8 consecutive years, with $488000.0 as the latest value for Q4 2024.

  • Quarterly Depreciation & Amortization (CF) fell 16.87% to $488000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2024, down 4.88% year-over-year, with the annual reading at $1.6 million for FY2025, 33.36% down from the prior year.
  • Depreciation & Amortization (CF) hit $488000.0 in Q4 2024 for Solid Biosciences, up from $405000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.3 million in Q2 2020 to a low of $327000.0 in Q1 2024.
  • Historically, Depreciation & Amortization (CF) has averaged $716500.0 across 5 years, with a median of $713500.0 in 2021.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 102.74% in 2020 and later tumbled 53.49% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $796000.0 in 2020, then decreased by 4.52% to $760000.0 in 2021, then dropped by 29.08% to $539000.0 in 2022, then grew by 8.91% to $587000.0 in 2023, then fell by 16.87% to $488000.0 in 2024.
  • Business Quant data shows Depreciation & Amortization (CF) for SLDB at $488000.0 in Q4 2024, $405000.0 in Q3 2024, and $1.2 million in Q2 2024.